Literature DB >> 17210661

Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.

David Piedrafita1, Endah Estuningsih, Jill Pleasance, Rhoda Prowse, Herman W Raadsma, Els N T Meeusen, Terry W Spithill.   

Abstract

Indonesian thin-tail (ITT) sheep resist infection by Fasciola gigantica by an immunological mechanism within 2 to 4 weeks of infection yet are susceptible to F. hepatica infection. Studies of ITT sheep show that little liver damage occurs following F. gigantica infection, suggesting that the invading parasites are killed within the peritoneum or shortly after reaching the liver. We investigated whether cells isolated from the peritoneums of ITT sheep could kill newly excysted juvenile F. gigantica in vitro and act as a potential mechanism of resistance against F. gigantica infection. Peritoneal cells from F. gigantica-infected sheep, rich in macrophages and eosinophils, mediated antibody-dependent cytotoxicity against juvenile F. gigantica in vitro. Cytotoxicity was dependent on contact between the parasite and effector cells. Isolated mammary gland eosinophils of F. gigantica-infected sheep, or resident peritoneal monocytes/macrophages from uninfected sheep, also killed the juvenile parasites in vitro. By using inhibitors, we show that the molecular mechanism of killing in these assays was dependent on the production of superoxide radicals by macrophages and eosinophils. In contrast, this cytotoxic mechanism was ineffective against juvenile F. hepatica parasites in vitro. Analysis of superoxide dismutase activity and mRNA levels showed that activity and gene expression were higher in F. hepatica than in F. gigantica, suggesting a possible role for this enzyme in the resistance of F. hepatica to superoxide-mediated killing. We suggest that ovine macrophages and eosinophils, acting in concert with a specific antibody, may be important effector cells involved in the resistance of ITT sheep to F. gigantica.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210661      PMCID: PMC1865704          DOI: 10.1128/IAI.01034-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Antagonistic effects of IL-4 and interferon-gamma (IFN-gamma) on inducible nitric oxide synthase expression in bovine macrophages exposed to gram-positive bacteria.

Authors:  T W Jungi; M Brcic; H Sager; D A Dobbelaere; A Furger; I Roditi
Journal:  Clin Exp Immunol       Date:  1997-09       Impact factor: 4.330

Review 2.  Fasciola antigens as vaccines against fascioliasis and schistosomiasis.

Authors:  G V Hillyer
Journal:  J Helminthol       Date:  2005-09       Impact factor: 2.170

3.  Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals.

Authors:  G M Mkoji; J M Smith; R K Prichard
Journal:  Int J Parasitol       Date:  1988-07       Impact factor: 3.981

4.  Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development.

Authors:  B Nare; J M Smith; R K Prichard
Journal:  Exp Parasitol       Date:  1990-05       Impact factor: 2.011

5.  A preliminary note on the susceptibility, prepatency and recovery of Fasciola gigantica in small laboratory animals.

Authors:  A M Mango; C K Mango; D Esamal
Journal:  J Helminthol       Date:  1972       Impact factor: 2.170

6.  Effect of Fasciola gigantica somatic extracts and excretory/secretory products on superoxide production by activated neutrophils.

Authors:  A El-Ghaysh; R J Turner; P M Brophy; J Barrett
Journal:  Vet Parasitol       Date:  1999-07       Impact factor: 2.738

7.  Acquisition of resistance against Fasciola gigantica by Indonesian thin tail sheep.

Authors:  J A Roberts; E Estuningsih; E Wiedosari; T W Spithill
Journal:  Vet Parasitol       Date:  1997-12-31       Impact factor: 2.738

8.  Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infected cattle, sheep, and goats and in macrophages stimulated in vitro.

Authors:  T W Jungi; H Pfister; H Sager; R Fatzer; M Vandevelde; A Zurbriggen
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

9.  Biochemical analysis of recombinant glutathione S-transferase of Fasciola hepatica.

Authors:  L Salvatore; G Wijffels; J L Sexton; M Panaccio; S Mailer; I McCauley; T W Spithill
Journal:  Mol Biochem Parasitol       Date:  1995-02       Impact factor: 1.759

10.  Fasciola hepatica in rats: transfer of immunity by serum and cells from infected to F. hepatica naive animals.

Authors:  G R Rajasekariah; M J Howell
Journal:  J Parasitol       Date:  1979-08       Impact factor: 1.276

View more
  19 in total

1.  A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.

Authors:  Verónica Noya; Natalie Brossard; Patricia Berasaín; Ernesto Rodríguez; Carolina Chiale; Daniel Mazal; Carlos Carmona; Teresa Freire
Journal:  Parasitol Res       Date:  2015-12-05       Impact factor: 2.289

2.  Vaccination of buffaloes with Fasciola gigantica recombinant glutathione S-transferase and fatty acid binding protein.

Authors:  Niranjan Kumar; Varghese Anju; Nagar Gaurav; Dinesh Chandra; S Samanta; S C Gupta; J Adeppa; O K Raina
Journal:  Parasitol Res       Date:  2011-07-13       Impact factor: 2.289

3.  Exploring the antigenic features of Fasciola hepatica rediae (Trematoda: Digenea) through the evaluation of different antigenic candidates for further monoclonal antibody generation.

Authors:  Annia Alba; Hilda M Hernández; Ricardo Marcet; Alejandro L Gil; Antonio A Vázquez; Mabel Figueredo; Jorge Sánchez; Hilda E Garay; Jorge Sarracent
Journal:  Parasitol Res       Date:  2014-06-13       Impact factor: 2.289

Review 4.  Immunity against helminths: interactions with the host and the intercurrent infections.

Authors:  Emmanuelle Moreau; Alain Chauvin
Journal:  J Biomed Biotechnol       Date:  2010-02-03

5.  A portrait of the transcriptome of the neglected trematode, Fasciola gigantica--biological and biotechnological implications.

Authors:  Neil D Young; Aaron R Jex; Cinzia Cantacessi; Ross S Hall; Bronwyn E Campbell; Terence W Spithill; Sirikachorn Tangkawattana; Prasarn Tangkawattana; Thewarach Laha; Robin B Gasser
Journal:  PLoS Negl Trop Dis       Date:  2011-02-01

6.  Superoxide Dismutase (SOD) Enzyme Activity Assay in Fasciola spp. Parasites and Liver Tissue Extract.

Authors:  M Assady; A Farahnak; A Golestani; Mr Esharghian
Journal:  Iran J Parasitol       Date:  2011-12       Impact factor: 1.012

7.  Fasciola hepatica vaccine: we may not be there yet but we're on the right road.

Authors:  Verónica Molina-Hernández; Grace Mulcahy; Jose Pérez; Álvaro Martínez-Moreno; Sheila Donnelly; Sandra M O'Neill; John P Dalton; Krystyna Cwiklinski
Journal:  Vet Parasitol       Date:  2015-01-15       Impact factor: 2.738

8.  A Trematode Parasite Derived Growth Factor Binds and Exerts Influences on Host Immune Functions via Host Cytokine Receptor Complexes.

Authors:  Azad A Sulaiman; Katarzyna Zolnierczyk; Ornampai Japa; Jonathan P Owen; Ben C Maddison; Richard D Emes; Jane E Hodgkinson; Kevin C Gough; Robin J Flynn
Journal:  PLoS Pathog       Date:  2016-11-02       Impact factor: 6.823

9.  Heme-Oxygenase-1 Expression Contributes to the Immunoregulation Induced by Fasciola hepatica and Promotes Infection.

Authors:  Paula Carasi; Ernesto Rodríguez; Valeria da Costa; Sofía Frigerio; Natalie Brossard; Verónica Noya; Carlos Robello; Ignacio Anegón; Teresa Freire
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

10.  Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica.

Authors:  Maria Teresa Ruiz-Campillo; Veronica Molina Hernandez; Alejandro Escamilla; Michael Stevenson; Jose Perez; Alvaro Martinez-Moreno; Sheila Donnelly; John P Dalton; Krystyna Cwiklinski
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.